COSTS DRUG SAVINGS USING A TEST-BASED STRATEGY VERSUS AN EMPIRIC DOSE ESCALATION IN PATIENTS WITH CROHN’S DISEASE LOOSING RESPONSE TO ANTI-TNF THERAPY

(1) University Hospital, Saint Etienne, France

(2) University Hospital, Lyon, France

(3) Hopital Beaujon, Paris, France

(4) Nukleus, Paris, France

(5) University Hospital, Nancy, France



This item was part of UEG Week 2014

This item can be cited as: United European Gastroenterology Journal; 2014: 2 (Supplement 1)